Cannabis essential oils unlock how camphor repels mosquitoes - new study
Peer-Reviewed Publication
Updates every hour. Last Updated: 17-Jun-2026 09:15 ET (17-Jun-2026 13:15 GMT/UTC)
From summer evenings to global disease prevention, mosquito repellents are a daily defense for billions of people, yet until now, scientists didn’t fully understand how mosquitoes themselves perceive these “keep away” signals. A new study has pinpointed an odorant receptor that helps mosquitoes detect a repellent odor and steer away. The researchers found that activating this receptor switches on a dedicated neural pathway that can override the insects’ attraction to human scents, producing clear avoidance behavior. By mapping the molecular and neural mechanism behind this response, the findings point to new strategies for designing more targeted and effective mosquito repellents.
Rytvela, an anti-inflammatory drug candidate, decreased premature birth and infant mortality when administered after the onset of preterm labor in a preclinical model. The current standard treatment for preterm labor, Nifedipine, failed to confer similar benefits. The researchers plan to begin clinical trials as Rytvela represents a promising treatment approach to safely prolong pregnancy and fetal growth while allowing newborn organs to continue developing in utero.
- uOttawa multidisciplinary team has built new hydrogels from synthetic peptides that can be customized as needed - a defining hallmark in the emerging era of personalized medicine. - Offers game-changing potential to impact future biomedical applications, from sealing traumatic wounds to closing surgical incisions. - Bonding strength is comparable to commercially available tissue adhesives.
Having a dog, cat or other pet can help older adults stay active and maintain a sense of purpose, but pet-related costs may increasingly strain their budgets, a new poll suggests.
Schizophrenia is a complex psychiatric disorder involving disruptions in neurotransmitters, neurodevelopment, immune function, and genetics. While current antipsychotics mainly target dopamine, they often fail to address negative and cognitive symptoms. This review synthesizes the latest findings on the pathophysiology of schizophrenia and highlights emerging treatments such as TAAR1 agonists, muscarinic modulators, NMDA enhancers, anti-inflammatory agents, and gut-brain axis interventions, paving the way for more precise and effective therapies.